TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,569,406 | -65.3% | 187,728 | +3.1% | 0.00% | -50.0% |
| Q2 2023 | $4,521,352 | +104.6% | 182,019 | +23.9% | 0.00% | +100.0% |
| Q1 2023 | $2,209,482 | +35.6% | 146,907 | +6.7% | 0.00% | 0.0% |
| Q4 2022 | $1,628,932 | +100.6% | 137,695 | +0.3% | 0.00% | +100.0% |
| Q3 2022 | $812,000 | +56.2% | 137,271 | +12.1% | 0.00% | 0.0% |
| Q2 2022 | $520,000 | -57.1% | 122,420 | -4.0% | 0.00% | 0.0% |
| Q1 2022 | $1,213,000 | -47.3% | 127,583 | +5.3% | 0.00% | 0.0% |
| Q4 2021 | $2,301,000 | -41.9% | 121,144 | +1.8% | 0.00% | -50.0% |
| Q3 2021 | $3,963,000 | -13.2% | 119,046 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $4,568,000 | -75.2% | 117,758 | -69.2% | 0.00% | -77.8% |
| Q1 2021 | $18,430,000 | +83.7% | 382,359 | +98.2% | 0.01% | +80.0% |
| Q4 2020 | $10,033,000 | +129.8% | 192,869 | +18.2% | 0.01% | +66.7% |
| Q3 2020 | $4,366,000 | -54.8% | 163,142 | -67.1% | 0.00% | -57.1% |
| Q2 2020 | $9,667,000 | +667.2% | 496,263 | +287.7% | 0.01% | +600.0% |
| Q1 2020 | $1,260,000 | -29.3% | 127,990 | -20.3% | 0.00% | 0.0% |
| Q4 2019 | $1,782,000 | +314.4% | 160,517 | +109.7% | 0.00% | – |
| Q3 2019 | $430,000 | +0.5% | 76,564 | +54.7% | 0.00% | – |
| Q2 2019 | $428,000 | -11.2% | 49,505 | -17.4% | 0.00% | – |
| Q1 2019 | $482,000 | +138.6% | 59,900 | +21.8% | 0.00% | – |
| Q4 2018 | $202,000 | -16.5% | 49,179 | +13.7% | 0.00% | – |
| Q3 2018 | $242,000 | -67.3% | 43,241 | -23.3% | 0.00% | -100.0% |
| Q2 2018 | $741,000 | -45.3% | 56,374 | -40.9% | 0.00% | 0.0% |
| Q1 2018 | $1,355,000 | +147.3% | 95,362 | +42.6% | 0.00% | – |
| Q4 2017 | $548,000 | -83.1% | 66,893 | -75.6% | 0.00% | -100.0% |
| Q3 2017 | $3,249,000 | +61.2% | 274,066 | +36.7% | 0.00% | +100.0% |
| Q2 2017 | $2,015,000 | +19.8% | 200,552 | +38.9% | 0.00% | 0.0% |
| Q1 2017 | $1,682,000 | +572.8% | 144,368 | +169.2% | 0.00% | – |
| Q4 2016 | $250,000 | -73.2% | 53,620 | -55.6% | 0.00% | -100.0% |
| Q3 2016 | $934,000 | -50.2% | 120,718 | -61.0% | 0.00% | -50.0% |
| Q2 2016 | $1,874,000 | +451.2% | 309,236 | +675.2% | 0.00% | – |
| Q1 2016 | $340,000 | -19.0% | 39,892 | +13.4% | 0.00% | – |
| Q4 2015 | $420,000 | +101.0% | 35,188 | +69.4% | 0.00% | – |
| Q3 2015 | $209,000 | -84.5% | 20,776 | -74.4% | 0.00% | -100.0% |
| Q2 2015 | $1,346,000 | +235.7% | 81,158 | +213.4% | 0.00% | – |
| Q1 2015 | $401,000 | -43.8% | 25,893 | -42.5% | 0.00% | -100.0% |
| Q4 2014 | $713,000 | +170.1% | 45,019 | +82.4% | 0.00% | – |
| Q3 2014 | $264,000 | -27.1% | 24,679 | -36.0% | 0.00% | – |
| Q2 2014 | $362,000 | +761.9% | 38,566 | +250.2% | 0.00% | – |
| Q4 2013 | $42,000 | – | 11,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |